Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease — Stella

Recruiting

Back to Autoimmune Diseases trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

China

Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310000, Hangzhou, Zhejiang

Key details

Phase

Very early testing

Sponsor

The Children's Hospital of Zhejiang University School of Medicine

Enrollment target

~36 participants

Started

January 2025

Primary completion

June 2028

Age range

3 Years and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov